IMPACT BIOMEDICINES
Impact Biomedicines is pioneering the development of life changing treatments for patients with complex cancers. The Company’s pipeline is centered around fedratinib, a potent and highly selective oral small molecule JAK2 kinase inhibitor that is being developed initially for the treatment of myelofibrosis and polycythemia vera.
IMPACT BIOMEDICINES
Industry:
Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.impactbiomedicines.com
Total Employee:
5001+
Status:
Active
Contact:
858-221-0950
Total Funding:
112 M USD
Technology used in webpage:
Starfield Technologies Proofpoint CSC Global DNS
Similar Organizations
CorVent Medical
CorVent Medical is developing smart, versatile, lifesaving ventilators for critical care.
Options MD
Options MD helps patients with treatment-resistant mental illnesses access better-performing treatments, faster.
Sirenas Marine Discovery
A Biomedical research organization
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
University Ambulatory Surgery Center
UASC focuses on providing the highest level of care and communication to our patient, physician specialists and their staff.
Current Advisors List
Current Employees Featured
Founder
Investors List
Oberland Capital
Oberland Capital investment in Debt Financing - Impact Biomedicines
Medicxi
Medicxi investment in Series A - Impact Biomedicines
Official Site Inspections
http://www.impactbiomedicines.com
- Host name: 165.160.13.20
- IP address: 165.160.13.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
